Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

HIV-1 decreases Nrf2/ARE activity and phagocytic function in alveolar macrophages.

Staitieh BS, Ding L, Neveu WA, Spearman P, Guidot DM, Fan X.

J Leukoc Biol. 2017 May 26. pii: jlb.4A0616-282RR. doi: 10.1189/jlb.4A0616-282RR. [Epub ahead of print]

PMID:
28550120
2.

Rhabdomyolysis as the first manifestation of human immunodeficiency virus infection.

Bhargava R, Abohashem Aly AA, Mertz JI, Mustafa R.

CEN Case Rep. 2016 May;5(1):48-50. doi: 10.1007/s13730-015-0189-7. Epub 2015 Aug 12.

3.

HIV-1 Tat Primes and Activates Microglial NLRP3 Inflammasome-Mediated Neuroinflammation.

Chivero ET, Guo ML, Periyasamy P, Liao K, Callen SE, Buch S.

J Neurosci. 2017 Mar 29;37(13):3599-3609. doi: 10.1523/JNEUROSCI.3045-16.2017. Epub 2017 Mar 7.

PMID:
28270571
4.

Antiretroviral Treatment in HIV-1-Positive Mothers: Neurological Implications in Virus-Free Children.

Coelho AV, Tricarico PM, Celsi F, Crovella S.

Int J Mol Sci. 2017 Feb 15;18(2). pii: E423. doi: 10.3390/ijms18020423. Review.

5.

Neuronal Cell Death and Degeneration through Increased Nitroxidative Stress and Tau Phosphorylation in HIV-1 Transgenic Rats.

Cho YE, Lee MH, Song BJ.

PLoS One. 2017 Jan 20;12(1):e0169945. doi: 10.1371/journal.pone.0169945. eCollection 2017.

6.

The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.

González ME.

Int J Mol Sci. 2017 Jan 10;18(1). pii: E126. doi: 10.3390/ijms18010126. Review.

7.

A Gap in Time: Extending our Knowledge of Temporal Processing Deficits in the HIV-1 Transgenic Rat.

McLaurin KA, Moran LM, Li H, Booze RM, Mactutus CF.

J Neuroimmune Pharmacol. 2017 Mar;12(1):171-179. doi: 10.1007/s11481-016-9711-8. Epub 2016 Oct 3.

PMID:
27699630
8.

Progression of temporal processing deficits in the HIV-1 transgenic rat.

McLaurin KA, Booze RM, Mactutus CF.

Sci Rep. 2016 Sep 6;6:32831. doi: 10.1038/srep32831.

9.

Selective developmental alterations in The HIV-1 transgenic rat: Opportunities for diagnosis of pediatric HIV-1.

McLaurin KA, Booze RM, Mactutus CF.

J Neurovirol. 2017 Feb;23(1):87-98. doi: 10.1007/s13365-016-0476-x. Epub 2016 Aug 18.

PMID:
27538996
10.

Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models.

Soontornniyomkij V, Kesby JP, Morgan EE, Bischoff-Grethe A, Minassian A, Brown GG, Grant I; Translational Methamphetamine AIDS Research Center (TMARC) Group.

J Neuroimmune Pharmacol. 2016 Sep;11(3):495-510. doi: 10.1007/s11481-016-9699-0. Epub 2016 Aug 2. Review.

PMID:
27484318
11.

Neuroinflammation and Behavior in HIV-1 Transgenic Rats Exposed to Chronic Adolescent Stress.

Rowson SA, Harrell CS, Bekhbat M, Gangavelli A, Wu MJ, Kelly SD, Reddy R, Neigh GN.

Front Psychiatry. 2016 Jun 20;7:102. doi: 10.3389/fpsyt.2016.00102. eCollection 2016.

12.

Combined chronic blockade of hyper-active L-type calcium channels and NMDA receptors ameliorates HIV-1 associated hyper-excitability of mPFC pyramidal neurons.

Khodr CE, Chen L, Dave S, Al-Harthi L, Hu XT.

Neurobiol Dis. 2016 Oct;94:85-94. doi: 10.1016/j.nbd.2016.06.008. Epub 2016 Jun 17.

PMID:
27326669
13.

Modulation Effect of HIV-1 Viral Proteins and Nicotine on Expression of the Immune-Related Genes in Brain of the HIV-1 Transgenic Rats.

Yang Z, Nesil T, Connaghan KP, Li MD, Chang SL.

J Neuroimmune Pharmacol. 2016 Sep;11(3):562-71. doi: 10.1007/s11481-016-9679-4. Epub 2016 May 4.

PMID:
27147085
14.
15.

Neurobehavioral Abnormalities in the HIV-1 Transgenic Rat Do Not Correspond to Neuronal Hypometabolism on 18F-FDG-PET.

Reid WC, Casas R, Papadakis GZ, Muthusamy S, Lee DE, Ibrahim WG, Nair A, Koziol D, Maric D, Hammoud DA.

PLoS One. 2016 Mar 24;11(3):e0152265. doi: 10.1371/journal.pone.0152265. eCollection 2016.

16.

Characterization of neuropathology in the HIV-1 transgenic rat at different ages.

Reid WC, Ibrahim WG, Kim SJ, Denaro F, Casas R, Lee DE, Maric D, Hammoud DA.

J Neuroimmunol. 2016 Mar 15;292:116-25. doi: 10.1016/j.jneuroim.2016.01.022. Epub 2016 Feb 3.

17.

HIV-1 transgenic rats display mitochondrial abnormalities consistent with abnormal energy generation and distribution.

Villeneuve LM, Purnell PR, Stauch KL, Callen SE, Buch SJ, Fox HS.

J Neurovirol. 2016 Oct;22(5):564-574. Epub 2016 Feb 3.

PMID:
26843384
18.

B-Cell-Deficient and CD8 T-Cell-Depleted Gnotobiotic Pigs for the Study of Human Rotavirus Vaccine-Induced Protective Immune Responses.

Wen K, Bui T, Weiss M, Li G, Kocher J, Yang X, Jobst PM, Vaught T, Ramsoondar J, Ball S, Clark-Deener S, Ayares D, Yuan L.

Viral Immunol. 2016 Mar;29(2):112-27. doi: 10.1089/vim.2015.0105. Epub 2016 Jan 29.

19.

Effect of Cocaine on Pulmonary Vascular Remodeling and Hemodynamics in Human Immunodeficiency Virus-Transgenic Rats.

Dalvi P, Spikes L, Allen J, Gupta VG, Sharma H, Gillcrist M, Montes de Oca J, O'Brien-Ladner A, Dhillon NK.

Am J Respir Cell Mol Biol. 2016 Aug;55(2):201-12. doi: 10.1165/rcmb.2015-0264OC.

PMID:
26820592
20.

HIV-1 Transgenic Rat Prefrontal Cortex Hyper-Excitability is Enhanced by Cocaine Self-Administration.

Wayman WN, Chen L, Hu XT, Napier TC.

Neuropsychopharmacology. 2016 Jul;41(8):1965-73. doi: 10.1038/npp.2015.366. Epub 2015 Dec 18.

Supplemental Content

Support Center